Cardiovascular Risk Stratification on the Basis of Surface Enhanced Raman Spectroscopy
NCT06399328 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 220
Last updated 2024-05-03
Summary
In the modern population, mortality and disability from cardiovascular diseases is predominant and is realized as a major medical and social problem. The study of mechanisms of development of age-related diseases, such as coronary heart disease (CHD), has demonstrated multiple qualitative and quantitative changes of metabolites in biological fluids of the body - blood, in the vascular wall, as well as in the tissues of vital organs. In routine clinical practice only about a dozen metabolic parameters are determined by standard laboratory methods.
The proposed approach belongs to a new scientific direction , wich development is aimed at individualization of approaches to risk stratification of cardiovascular diseases and their complications. The data obtained in this project will allow to create a base of medical knowledge about spectral characteristics of blood serum, which most fully reflect the metabolic profile associated with atherosclerosis of coronary arteries. Researchers offer so-called multiplex diagnostics when multiple parameters of a biological object obtained by serum biochemical analysis and optical scattering analysis are used. Recognition of this big data is possible only by methods of mathematical analysis, which can take into account the degree of deviations, their directionality in each point of the spectral characteristic.
Until recently, the standard setup for Raman light scattering studies had significant dimensions. The high cost of such installations made it difficult to widely use the method of optical spectroscopy for rapid analysis of medical objects. In recent years, the situation on the market of scientific instrumentation has changed radically, which allowed to significantly reduce and cheapen all components of Raman installations.This simplification and cheapening allows to bring optical research in medicine (optical biopsy) to a new level of use, directly into clinical laboratories.
Novelty: This area of research belongs to high-tech and is very little represented in Europe. The prospect of using Surface Enhanced Raman spectroscopy (SERS) to determine subclinical lesions of coronary arteries and for risk stratification of diseases associated with atherosclerosis is quite unique and wasn't explored yet.
Conditions
- Coronary Atherosclerosis of Native Coronary Artery
Interventions
- DIAGNOSTIC_TEST
-
Surface Enhanced Raman Spectroscopy
Spectral measurements of blood serum were performed on a silver nanoparticle substrate. Serum samples were collected and placed in sterile tubes with subsequent freezing at -18°C. Immediately before analysis, samples were thawed at room temperature. For spectral analysis, each 1.5 μL serum sample was applied to a substrate with a layer of silver nanoparticles and dried for 30 minutes. The spectral characteristics of serum were analyzed using an experimental bench consisting of a spectrometric system and a microscope (ADF U300, ADF, China). The spectra were excited in the near infrared range using a laser module with a center wavelength of 785 nm. Each of the obtained spectra represented a discrete set of 1700 parameters in the range of studied frequencies.
Sponsors & Collaborators
-
Samara Regional Clinical Hospital V.D. Seredavin
collaborator OTHER -
Samara State Medical University
lead OTHER
Principal Investigators
-
Petr A Lebedev, professor · chief of therapy chair of professional education department
Eligibility
- Min Age
- 30 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2023-09-15
- Primary Completion
- 2025-09-15
- Completion
- 2025-11-15
Countries
- Russia
Study Locations
More Related Trials
-
Correlation of Biomarkers With the Presence and Severity of Coronary Artery Disease
NCT05015270 ·Status: COMPLETED
-
Using Advanced CT Scans and Blood Markers to Better Understand Heart Damage and Recovery After a Heart Attack
NCT07268391 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Identification and Functional Study of Novel Biomarkers for Cardiovascular Diseases
NCT06690684 ·Status: ENROLLING_BY_INVITATION
-
Role of Endothelial Biomarkers in Patients With Coronary Artery Disease
NCT03146208 ·Status: UNKNOWN
-
Mechanical Dyssynchrony and Microvascular Dysfunction by SPECT
NCT06969547 ·Status: RECRUITING
-
Comparison of Cardiac Computed Tomography for the Detection of Coronary Artery Disease With Nuclear Stress Test
NCT00352937 ·Status: COMPLETED
-
Biomarkers for Cardiovascular Disease
NCT00109018 ·Status: COMPLETED
-
Correlation of FFR and iFR With Cardiac PET Perfusion in Patients With Severe Aortic Valve Stenosis
NCT04882488 ·Status: RECRUITING
-
A Study Of CS Reducer For Symptomatic Heart Failure With HFpEF And CMD
NCT07093528 ·Status: RECRUITING
-
Clinical Outcomes of Patients With Coronary Artery Disease
NCT06216847 ·Status: RECRUITING
-
Risk Evaluation by COronary CTA and Artificial IntelliGence Based fuNctIonal analyZing tEchniques - II
NCT05856110 ·Status: RECRUITING
-
PRE-DETERMINE Cohort Study
NCT01114269 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Infarct Size With 3D Rotational Angiography
NCT02857985 ·Status: COMPLETED ·Phase: NA
-
Evaluation of a Strategy Guided by Imaging Versus Systematic Coronary Angiography in Elderly Patients With Ischemia
NCT03289728 ·Status: UNKNOWN ·Phase: NA
-
The Relationship Between Microbiota and Coronary Ectasia
NCT06384703 ·Status: COMPLETED
-
Acute Coronary Syndrome in Patients With COVID-19
NCT05732597 ·Status: COMPLETED
-
Unstable Angina Pectoris in Comorbidity With Anxiety-depressive Syndrome
NCT04599621 ·Status: RECRUITING
-
Risk Factor Analysis for Coronary Atherosclerosis Measured by MDCT
NCT01589224 ·Status: COMPLETED
-
Clinical Evaluation of the CADenceTM System in Detection of Coronary Artery Diseases
NCT01584622 ·Status: WITHDRAWN ·Phase: NA
-
Using Retinal Photograph Based AI to Predict Incident Coronary Heart Disease
NCT06695273 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Rapid and Highly Sensitive Detection of Fluorescently-labeled Troponin in Patients Admitted With Chest Pain
NCT02897492 ·Status: COMPLETED
-
Assessment of Translesional Markers and Metabolomics
NCT00321139 ·Status: COMPLETED
-
CardiOvascular Risk and idEntificAtion of Potential High-risk Population in Acute Myocardial Infarction
NCT02385682 ·Status: COMPLETED
-
Imaging Modalities in Detection of Coronary Artery Disease in End-stage Renal Disease Patients
NCT00726921 ·Status: COMPLETED
-
High-sensitivity Troponin T in Acute Myocardial Infarction After Cardiac Valvular Surgery
NCT02518282 ·Status: UNKNOWN